Connecting People With Cancer to Employment Support

NCT ID: NCT07027449

Last Updated: 2025-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2028-01-31

Study Completion Date

2029-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if a clinical workflow that screens adult patients with cancer for challenges at work and refers them to supportive resources is feasible, appropriate, and acceptable to patients and staff members in 2 cancer care settings. The main questions it aims to answer are:

Is the clinical workflow feasible and acceptable to participants? Are study procedures feasible and acceptable to participants?

Patient participants will complete 2 surveys: 1 at the time of enrollment and 1 six months later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators will conduct a prospective single-arm study at 2 sites to pilot and iteratively adapt a clinical workflow intervention, implementation strategies, and associated study procedures. Investigators will implement the clinical workflow intervention across each study site, then recruit consecutive patients (n=50) to complete patient-reported measures at 2 time points (T1: enrollment; T2: 6-month follow-up. Investigators will recruit staff members (n=20) to complete survey measures at 2 time points (T1: beginning of pilot study period; T2: end of pilot study period).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Screening and Referral Workflow

Group Type EXPERIMENTAL

Screening and Referral Workflow

Intervention Type BEHAVIORAL

The Screening and Referral Workflow intervention will include screening eligible patients for employment-related needs and referring those who require support to community-based employment resources.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Screening and Referral Workflow

The Screening and Referral Workflow intervention will include screening eligible patients for employment-related needs and referring those who require support to community-based employment resources.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* visiting a participating medical or radiation oncology clinic for new diagnosis, treatment, or follow-up of any type of cancer;
* employed at the time of cancer diagnosis;
* age 18 or older;
* able to give full informed consent;
* able to communicate in English or Spanish.

Eligible Staff:

* age 18 or older;
* employed at one of the participating clinical sites.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Kansas Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rachel C. Forcino, PhD, MSc

Role: PRINCIPAL_INVESTIGATOR

University of Kansas Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rachel C. Forcino, PhD, MSc

Role: CONTACT

913-588-4742

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00161657

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

iCanWork: A Randomized Controlled Trial
NCT05546736 NOT_YET_RECRUITING NA
Effectiveness of a Cancer Exercise Program
NCT06039488 ENROLLING_BY_INVITATION NA